Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery. (I-PEEP-THO)
Primary Purpose
Lung Diseases
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
"Open-lung" protective ventilation strategy
"Standard" protective ventilation strategy
Sponsored by
About this trial
This is an interventional prevention trial for Lung Diseases focused on measuring Pulmonary resection surgery, One lung ventilation, Positive end-expiratory pressure, Esophageal pressure, Transpulmonary pressure, Lung compliance, Protective ventilation, Hypoxemia, Postoperative complications
Eligibility Criteria
Inclusion Criteria:
- To be over 18 years old,
- To be able to attend all scheduled visits and to comply with all trial procedures,
- To be scheduled for a lung cancer resection surgery (performed by either video-assisted thoracoscopy or thoracotomy).
Exclusion Criteria:
- Non-carcinologic indication of lung resection (e.g. Lung volume reduction for bullous emphysema reduction, lung abscess),
- Bilateral pulmonary resection surgery or history of lung resection surgery,
- Lung resection under sternotomy
- Contraindication to esophageal catheter (history of esophageal varices, hepatic cirrhosis child ≥ b, esophageal or gastric surgery, thoracic radiotherapy, latex allergy),
- ASA (American Society of Anesthesiologists) score ≥ 4,
- Chronic obstructive pulmonary disease GOLD III or IV (Forced Expiratory Volume, FEV<50%),
- Uncontrolled asthma (FEV <50%),
- Intracardiac shunt,
- Hemoglobinopathy making the SpO2 values invalid,
- Heart failure NYHA III or IV,
- Documented pulmonary hypertension (Mean Pulmonary Arterial Pressure at rest, mPAP>20 mmHg),
- To be under legal protection,
- Unable to read or write,
- Lack of informed consent, or unable to give consent,
- Refusal to participate in the study,
- Pregnancy in progress or planned during the study period, pregnant or nursing women,
- Not being affiliated to a French social security system or being a beneficiary of such a system.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Experimental
Arm Label
"Standard" protective ventilation
"Open lung" protective ventilation protocol
Arm Description
Patients receiving a positive-end expiratory pressure (PEEP) of 5 cmH2O
Patients with a titrated positive-end expiratory pressure (PEEP) corresponding to the best lung compliance calculated with transpulmonary pressure.
Outcomes
Primary Outcome Measures
The incidence of intraoperative hypoxemia
A SpO2<92% while the FiO2 is progressively decreased to 50% according to a standardized algorithm.
Secondary Outcome Measures
Hypoxemia events
The number of hypoxemia events, depth, and duration of hypoxemia.
The ventilatory parameters
Plateau pressure (mbar)
The ventilatory parameters
Driving PTP (cmH2O)
The ventilatory parameters
Airway driving pressure (cmH2O)
The ventilatory parameters
Lung compliance (ml/cmH2O)
Blood gas analysis
PaO2/FiO2 ratio (mmHg)
Blood gas analysis
PaCO2 (mmHg)
Blood gas analysis
pH
Blood gas analysis
HCO3- (mmol/L)
Intraoperative events related to hypoxemia
Additional recruitment maneuvers (cmH2O)
Intraoperative events related to hypoxemia
Additional bronchoscopy
Intraoperative events related to hypoxemia
Application of a selective PEEP to the operated lung using an auxiliary valve
Intraoperative events related to hypoxemia
Re-expansion and ventilation of the operated lung performed for hypoxemia
Intraoperative events not only due to hypoxemia
Atrial fibrillation (bpm), hypotension defined by systolic arterial pressure < 90 mmHg, needs for vasopressor,
Postoperative respiratory complications until postoperative day 28
Acute respiratory distress syndrome (ARDS) (diagnosed according to the Berlin definition), atelectasis or pleural effusion (documented on a postoperative chest radiograph), pneumonia (postoperative fever combined with an evocating chest radiograph, requiring antibiotics, with or without microbiologic confirmation), need for prolonged oxygen therapy (> 48 hours), need for high-flow nasal oxygen therapy, needs for postoperative invasive or noninvasive mechanical ventilation
Non-respiratory postoperative complications until postoperative day-28 (POD28)
Cardiovascular events such as myocardial infarction (troponin > threshold, combined with EKG modification or chest pain) or new-onset of atrial fibrillation (if the cardiac rhythm was sinus before surgery), acute kidney injury (defined by an AKIN stage ≥ 1), stroke (with CT scan or MRI confirmation) or transient ischemic attack, delirium (acutely disturbed state of mind)
The hospital stay
The in-hospital length of stay and hospital free-days at POD28, the hospital re-admission, ICU admission, and mortality at POD28 and POD90.
Full Information
NCT ID
NCT05525312
First Posted
August 26, 2022
Last Updated
May 26, 2023
Sponsor
University Hospital, Montpellier
1. Study Identification
Unique Protocol Identification Number
NCT05525312
Brief Title
Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.
Acronym
I-PEEP-THO
Official Title
Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery: "Open Lung" Approach With Individualized Level of Positive End-expiratory Pressure Titrated According to the Best Lung Compliance, Versus "Standard" Care: a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2023 (Anticipated)
Primary Completion Date
October 1, 2023 (Anticipated)
Study Completion Date
June 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
During thoracic surgery, one-lung ventilation (OLV) is associated with hypoxemia, lung injury, and perioperative respiratory complications. The level of positive-end expiratory pressure (PEEP) to apply during OLV remains controversial. The open-lung approach consists in setting a level of PEEP corresponding to the best lung compliance, using an esophageal catheter to measure the transpulmonary pressure. This approach has been effective in laparoscopic surgeries or acute respiratory distress syndrome, but has never been evaluated in thoracic surgery.
Detailed Description
Pulmonary resection surgery plays a key role in the treatment of localized lung cancer. During thoracic surgery, lung isolation is necessary. One-lung ventilation (OLV) is associated with frequent intraoperative respiratory complications, hypoxemia or lung injury related to mechanical ventilation. Intraoperative events increase the risk of postoperative complications resulting from either hypoxemia (atrial fibrillation, delirium, acute kidney injury) or lung injury (atelectasis, pulmonary edema, pneumonia, acute respiratory distress syndrome (ARDS)).
During OLV, a protective ventilation strategy is now recommended, including a low tidal volume (VT), using the lowest fraction of inspired oxygen (FiO2) due to the toxicity of high-oxygen concentration, and recruitment maneuvers (RM). But there is no consensus on the level of positive end-tidal pressure (PEEP) to apply. A low level of PEEP increases the risk of alveolar collapse, when a too high level leads to alveolar overdistension and increases lung dead space. The PEEP is usually arbitrary fixed to 5 cmH2O for every patient, which does not take into account the individual characteristics of the patient. Recent clinical trials in thoracic surgery showed that titration of PEEP according to the lowest airway driving pressure [end-inspiratory plateau pressure - total end-expiratory pressure], compared to a standard PEEP of 5 cmH2O, increased oxygenation and lung mechanics, and decreased significantly respiratory complications.
The transpulmonary pressure (PTP) is the instantaneous difference between alveolar pressure and pleural pressure. In order to optimize the alveolocapillary gas exchange, the level of PEEP should be titrated until achieving the best lung compliance (CL), defined by the ratio [(tidal volume) / (driving PTP = end-inspiratory PTP - end-expiratory PTP)]. As the tidal volume is set on the ventilator, the level of PEEP corresponding to the best CL is the one associated with the lowest driving PTP. The "open lung" strategy consists in setting the level of PEEP according to the best CL, which is an individualized approach, probably more physiologic than the standard care.
The esophageal pressure (PES) measured by an esophageal catheter is a validated estimation of the pleural pressure. Then, the PTP could be approximated by the difference [airway plateau pressure - PES]. The placement of an esophageal catheter is safe provided that the use respects contraindications (mainly esophageal disease or varices).
In ARDS, the open lung approach using an esophageal catheter was associated with a better clinical outcome than the standard non-individualized protocol. In laparoscopic surgery, the effects of PEEP on the PTP is also well described. In thoracic surgery, to date, monitoring PES and PTP is not part of the usual care. To our knowledge, only one study described the PTP changes during OLV. In this study, the best PEEP during OLV differed from one patient to another, which goes against the "one size fits all" theory. Thus, the PEEP should be titrated and individualized. Nevertheless, the airway driving pressure is only an approximation of the PTP, since it does not take into account the pleural pressure, which is a non-negligible extra-alveolar factor when talking about patients with lung or pleural diseases. Measuring the driving PTP using an esophageal catheter is certainly more accurate.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Diseases
Keywords
Pulmonary resection surgery, One lung ventilation, Positive end-expiratory pressure, Esophageal pressure, Transpulmonary pressure, Lung compliance, Protective ventilation, Hypoxemia, Postoperative complications
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
the "standard" protective ventilation versus an "open lung" protective ventilation protocol during a pulmonary resection surgery
Masking
Participant
Allocation
Randomized
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
"Standard" protective ventilation
Arm Type
Other
Arm Description
Patients receiving a positive-end expiratory pressure (PEEP) of 5 cmH2O
Arm Title
"Open lung" protective ventilation protocol
Arm Type
Experimental
Arm Description
Patients with a titrated positive-end expiratory pressure (PEEP) corresponding to the best lung compliance calculated with transpulmonary pressure.
Intervention Type
Procedure
Intervention Name(s)
"Open-lung" protective ventilation strategy
Intervention Description
In the "open-lung" group, the positive end-tidal pressure (PEEP) is titrated to match the best lung compliance. During a "PEEP decrement trial", PEEP is decreased from 20 cmH2O to 4 cmH2O by steps of 2 cmH2O/minute, and the driving the transpulmonary pressure (PTP) is calculated at each level of PEEP. In the "open-lung" group, the targeted PEEP corresponds to the lowest driving PTP during the "PEEP decrement trial", meaning the best lung compliance. Thereafter, the PEEP is set at this level and maintained until extubation.
Intervention Type
Procedure
Intervention Name(s)
"Standard" protective ventilation strategy
Intervention Description
In the "standard" group, the positive end-tidal pressure (PEEP) is arbitrarily set at 5 cmH2O, since this is the currently recommended level of PEEP, commonly used in control groups of previous clinical trials.
Primary Outcome Measure Information:
Title
The incidence of intraoperative hypoxemia
Description
A SpO2<92% while the FiO2 is progressively decreased to 50% according to a standardized algorithm.
Time Frame
During the Open-Lung Ventilation (OLV) period
Secondary Outcome Measure Information:
Title
Hypoxemia events
Description
The number of hypoxemia events, depth, and duration of hypoxemia.
Time Frame
During the OLV period
Title
The ventilatory parameters
Description
Plateau pressure (mbar)
Time Frame
T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
Title
The ventilatory parameters
Description
Driving PTP (cmH2O)
Time Frame
T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
Title
The ventilatory parameters
Description
Airway driving pressure (cmH2O)
Time Frame
T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
Title
The ventilatory parameters
Description
Lung compliance (ml/cmH2O)
Time Frame
T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
Title
Blood gas analysis
Description
PaO2/FiO2 ratio (mmHg)
Time Frame
T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
Title
Blood gas analysis
Description
PaCO2 (mmHg)
Time Frame
T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
Title
Blood gas analysis
Description
pH
Time Frame
T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
Title
Blood gas analysis
Description
HCO3- (mmol/L)
Time Frame
T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
Title
Intraoperative events related to hypoxemia
Description
Additional recruitment maneuvers (cmH2O)
Time Frame
During the OLV period
Title
Intraoperative events related to hypoxemia
Description
Additional bronchoscopy
Time Frame
During the OLV period
Title
Intraoperative events related to hypoxemia
Description
Application of a selective PEEP to the operated lung using an auxiliary valve
Time Frame
During the OLV period
Title
Intraoperative events related to hypoxemia
Description
Re-expansion and ventilation of the operated lung performed for hypoxemia
Time Frame
During the OLV period
Title
Intraoperative events not only due to hypoxemia
Description
Atrial fibrillation (bpm), hypotension defined by systolic arterial pressure < 90 mmHg, needs for vasopressor,
Time Frame
During the OLV period
Title
Postoperative respiratory complications until postoperative day 28
Description
Acute respiratory distress syndrome (ARDS) (diagnosed according to the Berlin definition), atelectasis or pleural effusion (documented on a postoperative chest radiograph), pneumonia (postoperative fever combined with an evocating chest radiograph, requiring antibiotics, with or without microbiologic confirmation), need for prolonged oxygen therapy (> 48 hours), need for high-flow nasal oxygen therapy, needs for postoperative invasive or noninvasive mechanical ventilation
Time Frame
Day 28
Title
Non-respiratory postoperative complications until postoperative day-28 (POD28)
Description
Cardiovascular events such as myocardial infarction (troponin > threshold, combined with EKG modification or chest pain) or new-onset of atrial fibrillation (if the cardiac rhythm was sinus before surgery), acute kidney injury (defined by an AKIN stage ≥ 1), stroke (with CT scan or MRI confirmation) or transient ischemic attack, delirium (acutely disturbed state of mind)
Time Frame
Day 28
Title
The hospital stay
Description
The in-hospital length of stay and hospital free-days at POD28, the hospital re-admission, ICU admission, and mortality at POD28 and POD90.
Time Frame
Day 28 and Day 90
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
To be over 18 years old,
To be able to attend all scheduled visits and to comply with all trial procedures,
To be scheduled for a lung cancer resection surgery (performed by either video-assisted thoracoscopy or thoracotomy).
Exclusion Criteria:
Non-carcinologic indication of lung resection (e.g. Lung volume reduction for bullous emphysema reduction, lung abscess),
Bilateral pulmonary resection surgery or history of lung resection surgery,
Lung resection under sternotomy
Contraindication to esophageal catheter (history of esophageal varices, hepatic cirrhosis child ≥ b, esophageal or gastric surgery, thoracic radiotherapy, latex allergy),
ASA (American Society of Anesthesiologists) score ≥ 4,
Chronic obstructive pulmonary disease GOLD III or IV (Forced Expiratory Volume, FEV<50%),
Uncontrolled asthma (FEV <50%),
Intracardiac shunt,
Hemoglobinopathy making the SpO2 values invalid,
Heart failure NYHA III or IV,
Documented pulmonary hypertension (Mean Pulmonary Arterial Pressure at rest, mPAP>20 mmHg),
To be under legal protection,
Unable to read or write,
Lack of informed consent, or unable to give consent,
Refusal to participate in the study,
Pregnancy in progress or planned during the study period, pregnant or nursing women,
Not being affiliated to a French social security system or being a beneficiary of such a system.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hélène Dr DAVID
Phone
06.65.84.95.24
Ext
+33
Email
h-david@chu-montpellier.fr
12. IPD Sharing Statement
Learn more about this trial
Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.
We'll reach out to this number within 24 hrs